Natural killer cells/therapy
Showing of 1 results
![](/-/media/images/for-clinicians/articles-and-news/2022/11/gastroimage-700x750.jpg?mw=304&h=326&w=304&la=en&hash=FF5E883C182D99C3A478D8FC55A18A03)
UH Seidman Cancer Center to Launch First-Ever Trial of NK Therapy and Vactosertib in Treating Colorectal Cancer and Hematological Malignancies
Trial employs new method of expanding and activating universal donor NK cells developed in Cleveland - Innovations in Cancer | Winter 2022
Results are loading...